Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

ClinicalTrials.gov ID: NCT04720157

Public ClinicalTrials.gov record NCT04720157. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 6:16 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care, Versus Standard of Care Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of 177Lu-PSMA-617 in combination with Standard of Care (SOC), versus Standard of Care alone, in adult male patients with Metastatic hormone sensitive prostate cancer (mHSPC). In this study, the SoC is defined as a combination of Androgen Receptor Directed Therapy + Androgen Deprivation Therapy. Approximately 1126 patients will be randomized in this study. As of 31-Jan-2024, 1144 participants were enrolled in 20 countries.

Study identification

NCT ID
NCT04720157
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,140 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 9, 2021 (Actual)
Primary completion
Jan 13, 2025 (Actual)
Completion
Feb 11, 2027 (Estimated)
Last update posted
Jun 8, 2026

2021 – 2027

United States locations

U.S. sites
70
U.S. states
29
U.S. cities
53
Facility City State ZIP Site status
Mayo Clinic - Arizona Mayo Clinic Hospital Scottsdale Arizona 85259 —
Mayo Clinic Arizona Scottsdale Arizona 85259 —
University of California San Diego - Moores Cancer Center La Jolla California 92093-0658 —
VA Greater LA Healthcare System Los Angeles California 90073 —
University of California LA Los Angeles California 90095 —
St. Joseph Hospital Orange California 92686 —
Univ Cali Irvine ALS Neuromuscular Orange California 92868 —
VA Palo Alto Health Care System Palo Alto California 94304-1207 —
Stanford University Medical Center Palo Alto California 94304 —
Sansum Clinic Santa Barbara California 93105 —
Providence Saint Johns Health Ctr Santa Monica California 90404 —
Univ Of Color Anschutz Med Center Aurora Colorado 80045 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
Hartford Hospital Hartford Connecticut 06102 —
Georgetown University-Lombardi Cancer Center Washington D.C. District of Columbia 20007 —
VA Medical Center Washington D.C. District of Columbia 20422 —
Mayo Clinic Jacksonville Jacksonville Florida 32224 —
Cancer Specialists of North Florida Jacksonville Florida 32256 —
University Of Miami Miami Florida 33136 —
Baptist Health South Miami Florida 33173 —
Florida Cancer Affiliates Panama City Florida 32405 —
University Cancer and Blood Center LLC Athens Georgia 30607 —
The Queens Medical Centre Honolulu Hawaii 96813 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
University of Chicago Chicago Illinois 60637 —
Hines VA Hospital Hines Illinois 60141 —
Parkview Research Center Fort Wayne Indiana 46845 —
Indiana University Indianapolis Indiana 46202 —
Tulane Cancer Center New Orleans Louisiana 70112 —
Ochsner Clinic Foundation New Orleans Louisiana 70121 —
Sidney Kimmel CCC At JH Baltimore Maryland 21231 —
Dana Farber Cancer Institute Boston Massachusetts 02115 —
Uni Of Michigan Health System Ann Arbor Michigan 48109 —
Corewell Health William Beaum Hosp Royal Oak Michigan 48073-6769 —
University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic Rochester Rochester Minnesota 55905 —
Mayo Clinic Rochester Minnesota 55905 —
University of Mississippi Med Ctr Jackson Mississippi 39216 —
St Louis University St Louis Missouri 63104 —
VA St Louis Health Care System St Louis Missouri 63106 —
Wash U School of Medicine St Louis Missouri 63110 —
Nebraska Cancer Specialists Omaha Nebraska 68130 —
Urology Cancer Center PC Omaha Nebraska 68130 —
University of New Mexico Albuquerque New Mexico 87131 0001 —
Weill Cornell Medical College New York New York 10021 —
Memorial Sloan Kettering Cancer Ctr New York New York 10065 —
Univ Of Rochester Cancer Ctr Rochester New York 14642 —
Montefiore Medical Center The Bronx New York 10467 —
Levine Cancer Institute Charlotte North Carolina 28203 —
Duke Univ Medical Center Durham North Carolina 27710 —
Duke Raleigh Hospital Raleigh North Carolina 27609 —
Cleveland Clinic Foundation Cleveland Ohio 44195 —
The Ohio State University Comprehensive Cancer Center Columbus Ohio 43221 —
Oregon Health Sciences University Portland Oregon 97239 —
Penn State Hershey Medical Center Hershey Pennsylvania 17033 —
Thomas Jefferson Univ Hosp Philadelphia Pennsylvania 19107 —
Univ of Pittsburgh Cancer Institute Pittsburgh Pennsylvania 15232 —
Carolina Urologic Research Center Myrtle Beach South Carolina 29572 —
Texas Oncology Amarillo Texas 79124 —
Dallas VA Medical Center Dallas Texas 75216 —
Univ of Texas Southwest Med Center Dallas Texas 75390-9034 —
MD Anderson Houston Texas 77030 —
UT Health Science Center Houston Texas 77030 —
UT Health San Antonio Mays Cancer Center San Antonio Texas 78229 —
University of Virginia Medical Center Charlottesville Virginia 22908 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Onco Hemato Asso of SW Virginia Roanoke Virginia 24014 —
Swedish Medical Center Seattle Washington 98122-4379 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 97 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04720157, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 8, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04720157 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →